Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

This publication has 21 references indexed in Scilit:

• Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children
  PLOS ONE, 2010
• Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
  PLOS ONE, 2009
• Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
  The Journal of Infectious Diseases, 2009
• Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
  PLOS ONE, 2009
• Impact of Artemisinin-Based Combination Therapy and Insecticide-Treated Nets on Malaria Burden in Zanzibar
  PLoS Medicine, 2007
• Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial
  The Lancet, 2005
• The global distribution of clinical episodes of Plasmodium falciparum malaria
  Nature, 2005
• WHO estimates of the causes of death in children
  The Lancet, 2005
• Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes
  International Journal for Parasitology, 2004
• Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum
  The Lancet, 2002